Advertisement
Canada markets close in 1 hour 41 minutes

  • S&P/TSX

    21,851.30
    +122.75 (+0.56%)
     

  • S&P 500

    5,056.26
    +37.87 (+0.75%)
     

  • DOW

    38,173.86
    +270.57 (+0.71%)
     

  • CAD/USD

    0.7312
    +0.0031 (+0.42%)
     

  • CRUDE OIL

    79.27
    +0.27 (+0.34%)
     

  • Bitcoin CAD

    80,994.34
    +1,915.01 (+2.42%)
     

  • CMC Crypto 200

    1,277.02
    +6.28 (+0.49%)
     

  • GOLD FUTURES

    2,317.60
    +6.60 (+0.29%)
     

  • RUSSELL 2000

    2,008.53
    +28.31 (+1.43%)
     

  • 10-Yr Bond

    4.5770
    -0.0180 (-0.39%)
     

  • NASDAQ

    15,805.68
    +200.20 (+1.28%)
     

  • VOLATILITY

    14.81
    -0.58 (-3.77%)
     

  • FTSE

    8,172.15
    +50.91 (+0.63%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6815
    +0.0022 (+0.32%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AS RATE-HIKE FEARS FADE, WITH APPLE ON DECK

Bitcoin rebounds to US$59,000 following record ETFs outflow

Stocks in play: Field Trip Health Ltd

Baystreet.ca

Announced today that Field Trip’s Co-Founder and CEO, Joseph del Moral, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in Citi’s Psychedelic Drug Video Call Series. Hosted by Neena Bitritto-Garg, Vice President Research Analyst, Biotech, the fireside chat with Field Trip will take place on Thursday, January 20, at 10:00 am Eastern Time. Field Trip Health Ltd shares T.FTRP are trading down $0.13 at $2.43.

Read: